LXEO
Lexeo Therapeutics, Inc. Common Stock · Healthcare · Biotechnology
Données momentum (gérants comparables) :
étendue des détenteurs +6.7% ·
flux d'actions +14.7% ·
nouvelles positions nettes +6.2%
— formule
Accumulation large — hausse des parts chez un plus grand nombre de détenteurs
Toutes les données de détention : gérants 13F suivis uniquement, positions en actions ordinaires, période de référence Q3 2025
| Trimestre | Détenteurs | Δ | Actions | Valeur déclarée | Nouveau | Sorties |
|---|---|---|---|---|---|---|
| Q2 2026 | 64 | +3 | 35.14M | $163.68M | +8 | −5 |
| Q1 2026 | 64 | -1 | 34.99M | $201.02M | +4 | −5 |
| Q4 2025 | 65 | +1 | 34.14M | $338.98M | +1 | — |
| Q3 2025 | 16 | +1 | 14.53M | $96.47M | +1 | — |
| Q2 2025 | 12 | -2 | 12.40M | $49.85M | — | −2 |
| Q1 2025 | 11 | +1 | 6.39M | $22.16M | +2 | −1 |
| Q4 2024 | 10 | +3 | 6.97M | $45.84M | +3 | — |
| Q3 2024 | 6 | +1 | 6.33M | $57.26M | +1 | — |
| Q2 2024 | 5 | — | 5.51M | $88.42M | — | — |
| # | Gérant | Actions | Δ actions | Valeur | Leur poids | Détenu | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 3.72M | +3.1% | $24.69M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 3.72M | +3.1% | $24.69M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 3 | Millennium Management ✦ | 2.31M | -18.4% | $15.36M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passif) | 2.23M | +11.2% | $14.78M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passif) | 2.23M | +11.2% | $14.78M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | The Vanguard Group ✦ (passif) | 2.23M | +11.2% | $14.78M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passif) | 2.17M | +18.8% | $14.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passif) | 2.17M | +18.8% | $14.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passif) | 2.17M | +18.8% | $14.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passif) | 2.17M | +18.8% | $14.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passif) | 2.17M | +18.8% | $14.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passif) | 2.17M | +18.8% | $14.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passif) | 2.17M | +18.8% | $14.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 1.94M | +199.7% | $12.89M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Geode Capital Management ✦ (passif) | 721.88K | +24.9% | $4.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | Geode Capital Management ✦ (passif) | 721.88K | +24.9% | $4.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (passif) | 544.85K | +6.2% | $3.62M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 347.92K | +84.4% | $2.31M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 347.92K | +84.4% | $2.31M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 347.92K | +84.4% | $2.31M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 347.92K | +84.4% | $2.31M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 347.92K | +84.4% | $2.31M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | Renaissance Technologies ✦ | 149.30K | +40.6% | $991,352 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Goldman Sachs Group ✦ | 142.40K | — | $945,549 | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Goldman Sachs Group ✦ | 142.40K | — | $945,549 | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 98.06K | — | $651,097 | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 98.06K | — | $651,097 | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 98.06K | — | $651,097 | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 98.06K | — | $651,097 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 98.06K | — | $651,097 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 98.06K | — | $651,097 | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Two Sigma Investments ✦ | 84.76K | +22.4% | $562,826 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 28.72K | — | $190,688 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 28.72K | — | $190,688 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 28.72K | — | $190,688 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 28.72K | — | $190,688 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 13.43K | +14.3% | $89,195 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | D. E. Shaw & Co. ✦ | 12.82K | Nouveau | $85,112 | 0.0% | New | 1 | SEC ↗ |
| 39 | T. Rowe Price ✦ | 11.96K | +14.8% | $80,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
« Leur pondération » = la part de la position dans la valeur des actions 13F déclarées de ce gérant — la mesure de conviction. ✦ = gérant sélectionné.
Nouveaux acheteurs
| D. E. Shaw & Co. | $85,112 | 0.0% |
Sorti(e)
| Aucune sortie suivie ce trimestre. |
Contexte marché global: parmi TOUS les déposants 13F (données structurées SEC, Q1 2026): 137 détenteurs, 79.80M actions, $457.81M déclaré. Il s'agit d'une période différente et plus ancienne que les chiffres de l'univers suivi ci-dessus ; les deux ne sont jamais mélangés.
Ce que les détenteurs suivis de ce titre détiennent le plus souvent par ailleurs — nombre de détentions partagées, sans relation fondamentale sous-jacente.
Achats sur le marché libre (P)
Aucun achat d'initié sur le marché libre dans notre fenêtre de couverture.
Ventes sur le marché libre (S)
Officer, Director · 3.35K act. · $16,562
Officer · 1.30K act. · $6,464
Officer · 4.12K act. · $20,203
Les attributions, exercices et retenues fiscales ne sont jamais comptabilisés comme des achats ou des ventes ici. Méthodologie